+ Translate

An account of 17 years of study of African trypanosomiasis (Trypanosoma gambiense) in children aged 0 to 6 years. A review of 227 cases

, : An account of 17 years of study of African trypanosomiasis (Trypanosoma gambiense) in children aged 0 to 6 years. A review of 227 cases. Medecine Tropicale 45(3): 251-257

From 1968 to 1984, 227 children aged 0 to 6 years were treated for trypanosomiasis at the General Hospital at Fontem, Cameroon, an area hyperendemic for T. gambiense. 46 were < one year old, including 7 neonates with congenital infection (as demonstrated by the presence of T. gambiense in blood and/or CSF). Many symptoms diagnostic of trypanosomiasis in adults were absent and the nervous system became rapidly involved - 217 of the children were in phase 2 of sleeping sickness.

(PDF 0-2 workdays service)

Accession: 001297074

Submit PDF Full Text: Here

Submit PDF Full Text

No spam - Every submission is manually reviewed

Due to poor quality, we do not accept files from Researchgate

Submitted PDF Full Texts will always be free for everyone
(We only charge for PDFs that we need to acquire)

Select a PDF file:

Related references

Triolo, N.; Trova, P.; Fusco, C.;, J., 1985: Report on l7 years of studies of human African trypanosomiasis caused by T. gambiense in children 0-6 years of age. The authors present 227 cases of human African trypanosomiasis in children between 0 and 6 years, which have been observed for 17 years in the hyperendemic area of Fontem, Cameroon. These cases deal with a subject seldom described in medical liter...

Sina, G.; Testa, G.; Triolo, N.; Trova, P.; Cramet, B., 1979: Some new cases of congenital human African trypanosomiasis (Trypanosoma gambiense). A description is given of cases of transplacental transmission of Trypanosoma gambiense at Fontem, Cameroon,. In one case, 2 non-identical twins were found to be infected. One child of another mother died soon after birth but the other 3 children...

Bertrand, E.; Baudin, L.; Vacher, P.; Sentilhes, L.; Ducasse, B.; Veyret, V., 1967: Impairment of the heart in 100 cases of African trypanosomiasis due to Trypanosoma gambiense. Bulletin de la Societe de Pathologie Exotique et de Ses Filiales 60(14): 360-369

Adams J.H.; Haller L.; Boa F.Y.; Doua F.; Dago A.; Konian K., 1986: Human african trypanosomiasis trypanosoma brucei gambiense a study of 16 fatal cases of sleeping sickness with some observations on acute reactive arsenical encephalopathy. The principal clinical and pathological findings in 16 fatal cases of human African trypanosomiasis caused by T. b. Gambiense are described. The changes in the brain took the form of a non-specific lymphoplasmacytic meningo-encephalitis of varying...

Bertrand E.; Baudin L.; Vacher P.; Sentilhes L.; Ducasse B.; Veyret V., 1967: Heart impairment in 100 cases of african trypanosomiasis due to trypanosoma gambiense human. Bulletin de la Societe de Pathologie Exotique 60(4): 360-369

Sina, G.; Triolo, N.; Trova, P.; Clabaut, J.M., 1977: Arsenic encephalopathy in the treatment of human african trypanosomiasis trypanosoma gambiense report on 16 cases. The incidence of arsenical encephalopathy among 1066 patients with human African trypanosomiasis [HAT] treated with Arsobal [melarsoprol] in the Catholic Mission Hospital (United Republic of Cameroon) is reported. The incidence is 1.5% (16 cases)...

Bertrand, E.; Serie, F.; Rive, J.; Compaore, P.; Sentilhes, L.; Baudin, L.; Renambot, J.; Chauvet, J.; Ekra, A.; Assamoi, M.O., 1974: Current aspects of the cardiac symptoms in African human trypanosomiasis due to Trypanosoma gambiense (apropos of 194 cases). Acta Cardiologica 29(5): 363-381

Anonymous, 1998: Report on a meeting of the product development team for African trypanosomiasis chemotherapy to review the comparative study of 14-day versus 7-day treatment of late stage T. b. gambiense African trypanosomiasis with eflornithine, WHO, Geneva, 14 July 1998. During July 1993-February 1996, a total of 120 patients from 4 African countries (Cote d'Ivoire, Congo, Democratic Republic of Congo (DRC), Uganda) were recruited to a multicentre, randomized comparative study evaluating the efficacy of a 14-...

Ilboudo, H.; Camara, O.; Ravel, S.; Bucheton, B.; Lejon, V.; Camara, M.; Kaboré, J.; Jamonneau, V.; Deborggraeve, S., 2016: Trypanosoma brucei gambiense Spliced Leader RNA Is a More Specific Marker for Cure of Human African Trypanosomiasis Than T. b. gambiense DNA. To assess the efficacy of treatment for human African trypanosomiasis, accurate tests that can discriminate relapse from cure are needed. We report the first data that the spliced leader (SL) RNA is a more specific marker for cure of human African...

Gehrig, S.; Efferth, T., 2008: Development of drug resistance in Trypanosoma brucei rhodesiense and Trypanosoma brucei gambiense. Treatment of human African trypanosomiasis with natural products (Review). Human African trypanosomiasis is an infectious disease which has resulted in the deaths of thousands of people in Sub-Saharan Africa. Two subspecies of the protozoan parasite Trypanosoma brucei are the causative agents of the infection, whereby T....